Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Feb 2010 07:00

RNS Number : 9063G
Assura Group Limited
10 February 2010
 



10 February 2010

 

Assura Group Limited ("Assura" or the "Company")

 

Third Quarter Interim Management Statement

 

Assura, one of the leading healthcare companies in the UK, today publishes the following Interim Management Statement covering the period from 1 October 2009 to date.

 

There have been no significant changes to the financial position of the Company since the publication of the Interim Results on 26 November 2009.

 

Highlights:

 

·; Q3 Group revenues up 16 per cent compared to the same quarter last year.1

 

·; Group revenues for the nine months ended 31 December 2009 have risen to £42.2m (£35.6m).

 

·; Rental growth in the property portfolio averaging 3.2 per cent per annum based on 48 reviews conducted so far this year, increasing the rent roll by £470k. Rent roll at 31 December 2009 was £22.3m.2

 

·; Q3 pharmacy revenues up 13 per cent to £8.3m compared to the same quarter last year. Number of prescription items up 16 per cent compared to Q3 of last year.3

 

·; Strong growth in GPCo revenues rising to £7.6m for the nine months ended 31 December 2009, of which £3.5m was generated in Q3.4

 

·; Net debt as at 31 December 2009 was £222m, drawn from total facilities of £240m.

 

·; On 31 December 2009, the Company repaid £8.5m to National Australia Bank ("NAB") reducing the debt outstanding (and facility) to £160m ahead of the 31 March 2010 deadline. The Company is due to repay a further £30m to NAB by 31 March 2011.

 

·; The Company has already agreed terms (subject to contract) with Santander for a new £30m five year debt facility in order to achieve the above repayment due to NAB in 2011.

 

1 Excludes revenues in GPCos.

2 Including the rental value of own premises.

3 Excludes 50% share of revenue derived from pharmacies owned in joint venture with GP Care.

4 GPCo revenue is not included in overall Group revenues.

 

Current trading

 

Since the end of Q3, the Company has continued to trade in line with the Board's expectations.

 

Offer period

 

Further to the announcement on 15 January 2010, the Board confirms that the Company has received preliminary approaches which may or may not lead to an offer being made for the Company.

 

Further to the Company's statement on 26 November 2009 concerning its GPCo business, the Board confirms that the Company has entered into exclusive discussions with another party regarding the sale of a majority interest in this business. A further announcement will be made as appropriate.

 

Rule 19.11 disclosure

 

In accordance with Rule 19.11 of the Code, a copy of this Announcement will be published on the Assura website: www.assuragroup.co.uk.

 

Ends.

 

Enquiries:

 

Richard Burrell / Louise Bathersby: Assura Group, 020 7107 3800

Ben Atwell: Financial Dynamics, 020 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFSEFIIAIII
Date   Source Headline
31st May 20247:00 amRNSAnnual Report & Notice of AGM
30th May 202411:05 amRNSDirector/PDMR Shareholding
29th May 20247:00 amRNSNotice of Dividend
21st May 20243:14 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSAppointment of Joint Corporate Broker
21st May 20247:00 amRNSAssura plc Full Year Results 2024
21st May 20247:00 amRNSAssura & USS announce £250m joint venture
8th May 20243:59 pmRNSDirector/PDMR Shareholding
1st May 20242:30 pmRNSHolding(s) in Company
1st May 20247:00 amRNSNotice of Year End Results
30th Apr 20247:00 amRNSTotal Voting Rights
16th Apr 20247:40 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSScrip Dividend Declaration
22nd Mar 20242:18 pmRNSHolding(s) in Company
14th Mar 20248:30 amRNSScrip Calculation Price
6th Mar 20241:26 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSNotice of Dividend
8th Feb 20242:00 pmRNSCapital Markets Event
7th Feb 20242:33 pmRNSDirector/PDMR Shareholding
1st Feb 20249:32 amRNSTotal Voting Rights
16th Jan 20248:26 amRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
9th Jan 20248:59 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSScrip Dividend Declaration
21st Dec 20234:20 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSScrip Calculation Price
6th Dec 20232:57 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSNotice of Dividend
16th Nov 20237:00 amRNSAssura Plc Interim Results
8th Nov 20232:32 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSAppointment of Board Fellow
31st Oct 20237:00 amRNSNotice of Interim Results
31st Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20232:04 pmRNSDirector/PDMR Shareholding
9th Oct 202311:13 amRNSDirector/PDMR Shareholding
9th Oct 20238:11 amRNSScrip Dividend Declaration
9th Oct 20237:00 amRNSRefinancing of RCF & new sustainability linkage
9th Oct 20237:00 amRNSTrading Update
18th Sep 20239:51 amRNSVesting and sale of restricted shares
14th Sep 20239:20 amRNSScrip Calculation Price
31st Aug 20237:00 amRNSNotice of Dividend
24th Aug 20238:36 amRNSHolding(s) in Company
8th Aug 20235:05 pmRNSDirector/PDMR Shareholding
31st Jul 20239:57 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSDevelopment update
14th Jul 20231:47 pmRNSDirector/PDMR Shareholding
13th Jul 20234:47 pmRNSExercise of Nil Cost Options under PSP
12th Jul 20234:36 pmRNSDirector/PDMR Shareholding
10th Jul 202312:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.